Skip to main content
. 2022 Mar 30;14(7):1750. doi: 10.3390/cancers14071750
SOS Suppression of Splicing
NMD Nonsense Mediated mRNA Decay
Pol II RNA Polymerase II
RNP Ribonucleoprotein
snRNP small nuclear RNP
AS Alternative Splicing
SS Splice Site
hnRNP heterogenous nuclear Ribonucleoproteins
PTCs Premature Termination Codons
NAS Nonsense-mediated Altered Splicing
ORF Open Reading Frame
LSS Latent 5′ Splice Site
Ini-tRNA initiator-tRNA
NCL Nucleolin
CAD31 CAD-Mut31
GEO Gene Expression Omnibus
TBR1 T box brain 1
SV2B Synaptic Vesicle glycoprotein 2B
OD Oligodendroglioma
ODII Oligodendroglioma Grade II
ODIII Oligodendroglioma Grade III
BC Breast Cancer
GC Glioma Cancer
EPB49 Erythrocyte membrane protein band 4.9 (Dematin)
LPCAT4 Lysophosphatidylcholine acyltransferase 4
MET Met proto-oncogene (hepatocyte growth factor receptor)
PRKAA2 Protein kinase, AMP-activated, alpha 2 catalytic subunit
VHP Villin Headpiece
PlsC Phosphate acyltransferases
Sema Semaphorin domain
PSI Plexins, Semaphorins and Integrins
IPT Ig-like, plexins, transcription factors
TyrKc Tyrosine kinase
S_TKc Serine/Threonine protein kinases
BRCA Breast invasive carcinoma
GBM Glioblastoma multiforme
LGG Brain Lower Grade Glioma
GEPIA Gene Expression Profiling Interactive Analysis
DMTN Dematin
AMPK AMP-activated protein Kinase